News

Published on 14 Jan 2024 on GuruFocus.com via Yahoo Finance

Seth Klarman's Firm Exits Atara Biotherapeutics Inc Holding

Article preview image

Overview of Seth Klarman (Trades, Portfolio)'s Recent Stock Transaction

Warning! GuruFocus has detected 7 Warning Signs with ATRA.

Renowned value investor Seth Klarman (Trades, Portfolio), through The Baupost Group, has recently divested the firm's entire stake in Atara Biotherapeutics Inc (NASDAQ:ATRA). The transaction, which took place on December 31, 2023, saw a complete sell-out of the position, with a total of 9,773,616 shares offloaded. This move has had a noticeable impact on Klarman's portfolio, reducing its exposure to the healthcare sector.

Read the rest of the article
NASDAQ.ATRA price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
After losing 76% in the past year, Atara Biotherapeutics, Inc. (NASDAQ:ATRA) institutional owners...

Key Insights Institutions' substantial holdings in Atara Biotherapeutics implies that they have s...

Simply Wall St. via Yahoo Finance 31 Jan 2024
Seth Klarman's Firm Exits Atara Biotherapeutics Inc Holding

Overview of Seth Klarman (Trades, Portfolio)'s Recent Stock Transaction Warning! GuruFocus has de...

GuruFocus.com via Yahoo Finance 14 Jan 2024
Billionaire Seth Klarman’s Biotech Stock Picks

In this article, we discuss billionaire Seth Klarman’s biotech stock picks. To skip the detailed ...

Insider Monkey via Yahoo Finance 22 Nov 2023
Atara Biotherapeutics (ATRA) Slumps 57% in a Month: Here's Why

Atara Biotherapeutics ATRA is a biotech company focused on developing off-the-shelf cell therapie...

Zacks · via Yahoo Finance 14 Nov 2023
Why AppLovin Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - AppLovin...

Now Read This: Disney, US Foods And 3 Stocks To Watch Heading Into Thursday

Benzinga 9 Nov 2023
Why Atara Biotherapeutics (ATRA) Shares Are Plummeting Today - Atara Biotherapeutics (NASDAQ:ATRA)

Atara Biotherapeutics, Inc. ATRA shares are trading lower after the company said that primary ana...

Benzinga 9 Nov 2023
US Stocks Mostly Flat; Jobless Claims Decline In Latest Week - Atara Biotherapeutics (NASDAQ:ATRA),...

U.S. stocks traded mostly flat this morning, following the release of jobless claims data. Follow...

Benzinga 9 Nov 2023
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.65%

U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.65%

Investing.com 8 Nov 2023
Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Q3 2023 Earnings Call Transcript

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Q3 2023 Earnings Call Transcript November 4, 2023 Opera...

Insider Monkey via Yahoo Finance 5 Nov 2023
Atara Biotherapeutics Inc (ATRA) Announces Q3 2023 Financial Results and Expanded Global Partnership

Atara Biotherapeutics Inc (NASDAQ:ATRA) announced its Q3 2023 financial results and an expanded g...

GuruFocus.com via Yahoo Finance 2 Nov 2023

Copyright Statfolio @ 2024

Social Accounts